GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism
Marie Helene Schernthaner-Reiter(Medical University of Vienna), Greisa Vila(Medical University of Vienna), Bianca Itariu(University of Vienna), Christian Anderwald(National Research Council), Giovanni Pacini(National Research Council), Michael Krebs(Medical University of Vienna), Martin Clodi, Thomas M. Stulnig(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Bernhard Ludvik(Medical University of Vienna), Miriam Promintzer‐Schifferl(Medical University of Vienna), A Luger(Universitat Autònoma de Barcelona), Andrea Tura(National Academies of Sciences, Engineering, and Medicine)
Cited by 37
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|857
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis
|The Lancet|1993|520
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340